Patterns and outcomes of red blood cell transfusion in patients undergoing percutaneous coronary intervention

JAMA

Volumn 311, Issue 8, 2014, Pages 836-843

  Sherwood, Matthew W ^a   Wang, Yongfei ^b   Curtis, Jeptha P ^b   Peterson, Eric D ^a   Rao, Sunil V ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DIABETES MELLITUS; DISEASE ASSOCIATION; ERYTHROCYTE TRANSFUSION; FEMALE; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; UNITED STATES;

EID: 84896739377     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2014.980     Document Type: Article

References (28)

1. Chatterjee S, Wetterslev J, Sharma A, Lichstein E, Mukherjee D. Association of blood transfusion with increased mortality in myocardial infarction. JAMA Intern Med. 2013;173(2):132-139.
2. Jolicoeur EM, O'Neill WW, Hellkamp A, et al APEX-AMI Investigators. Transfusion and mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Eur Heart J. 2009;30(21):2575-2583.
3. Nikolsky E, Mehran R, Sadeghi HM, et al. Prognostic impact of blood transfusion after primary angioplasty for acute myocardial infarction. JACC Cardiovasc Interv. 2009;2(7):624-632.
4. Shishehbor MH, Madhwal S, Rajagopal V, et al. Impact of blood transfusion on short- and long-term mortality in patients with ST-segment elevation myocardial infarction. JACC Cardiovasc Interv. 2009;2(1):46-53.
5. Aronson D, Dann EJ, Bonstein L, et al. Impact of red blood cell transfusion on clinical outcomes in patients with acute myocardial infarction. Am J Cardiol. 2008;102(2):115-119.
6. Wu WC, Rathore SS, Wang Y, Radford MJ, Krumholz HM. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med. 2001;345(17):1230-1236. (Pubitemid 34951486)
7. Rao SV, Jollis JG, Harrington RA, et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA. 2004;292(13):1555-1562. (Pubitemid 39314961)
8. Rao SV, Eikelboom JA, Granger CB, Harrington RA, Califf RM, Bassand JP. Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes. Eur Heart J. 2007;28(10):1193-1204. (Pubitemid 47343833)
9. Doyle BJ, Rihal CS, Gastineau DA, Holmes DR Jr. Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention. J Am Coll Cardiol. 2009;53(22):2019-2027.
10. Sabatine MS, Morrow DA, Giugliano RP, et al. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation. 2005;111(16):2042-2049. (Pubitemid 40577898)
11. Pilgrim T, Vetterli F, Kalesan B, et al. The impact of anemia on long-term clinical outcome in patients undergoing revascularization with the unrestricted use of drug-eluting stents. Circ Cardiovasc Interv. 2012;5(2):202-210.
12. Carson JL, Grossman BJ, Kleinman S, et al. Red blood cell transfusion: a clinical practice guideline from the AABB. Ann Intern Med. 2012;157(1):49-58.
13. Yang X, Alexander KP, Chen AY, et al CRUSADE Investigators. The implications of blood transfusions for patients with non-ST-segment elevation acute coronary syndromes. J Am Coll Cardiol. 2005;46(8):1490-1495. (Pubitemid 41446184)
14. Moscucci M, Ricciardi M, Eagle KA, et al. Frequency, predictors, and appropriateness of blood transfusion after percutaneous coronary interventions. Am J Cardiol. 1998;81(6):702-707. (Pubitemid 28146443)
15. Marso SP, Amin AP, House JA, et al National Cardiovascular Data Registry. Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention. JAMA. 2010;303(21):2156-2164.
16. Brindis RG, Fitzgerald S, Anderson HV, Shaw RE, Weintraub WS, Williams JF. The American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR). J Am Coll Cardiol. 2001;37(8):2240-2245.
17. Moussa I, Hermann A, Messenger JC, et al. The NCDR Cath PCI Registry: a US national perspective on care and outcomes for percutaneous coronary intervention. Heart. 2013;99(5):297-303.
18. Peterson ED, Dai D, DeLong ER, et al NCDR Registry Participants. Contemporary mortality risk prediction for percutaneous coronary intervention. J Am Coll Cardiol. 2010;55(18):1923-1932.
19. Mehta SK, Frutkin AD, Lindsey JB, et al National Cardiovascular Data Registry. Bleeding in patients undergoing percutaneous coronary intervention. Circ Cardiovasc Interv. 2009;2(3):222-229.
20. Carson JL, Terrin ML, Noveck H, et al FOCUS Investigators. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med. 2011;365(26):2453-2462.
21. Cooper HA, Rao SV, Greenberg MD, et al. Conservative versus liberal red cell transfusion in acute myocardial infarction (the CRIT Randomized Pilot Study). Am J Cardiol. 2011;108(8):1108-1111.
22. Hébert PC, Wells G, Blajchman MA, et al Transfusion Requirements in Critical Care Investigators for the Canadian Critical Care Trials Group. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med. 1999;340(6):409-417. (Pubitemid 29084771)
23. Corwin HL, Gettinger A, Pearl RG, et al. The CRIT study: anemia and blood transfusion in the critically ill - current clinical practice in the United States. Crit Care Med. 2004;32(1):39-52. (Pubitemid 38125561)
24. Hill SR, Carless PA, Henry DA, et al. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev. 2002;(2):CD002042.
25. Freudenberger RS, Carson JL. Is there an optimal hemoglobin value in the cardiac intensive care unit? Curr Opin Crit Care. 2003;9(5):356-361. (Pubitemid 37204789)
26. Hébert PC, Yetisir E, Martin C, et al Transfusion Requirements in Critical Care Investigators for the Canadian Critical Care Trials Group. Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? Crit Care Med. 2001;29(2):227-234. (Pubitemid 32171763)
27. Carson JL, Brooks MM, Abbott JD, et al. Liberal vs restrictive transfusion thresholds for patients with symptomatic coronary artery disease. Am Heart J. 2013;165(6):964-971.
28. Rao SV, Califf RM. Is old blood bad blood? Am Heart J. 2010;159(5):710-712.